Literature DB >> 22472978

mRNA leapfrogs DNA to show promise for therapeutic gene transfer.

Eli Gilboa1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22472978      PMCID： PMC3321584          DOI： 10.1038/mt.2012.31

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  11 in total

1.  Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA.

Authors:  R D Granstein; W Ding; H Ozawa
Journal:  J Invest Dermatol       Date:  2000-04       Impact factor: 8.551

Review 2.  Tumor vaccination using messenger RNA: prospects of a future therapy.

Authors:  Sebastian Kreiter; Mustafa Diken; Abderraouf Selmi; Özlem Türeci; Ugur Sahin
Journal:  Curr Opin Immunol       Date:  2011-04-13       Impact factor: 7.486

3.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.

Authors:  Katalin Karikó; Hiromi Muramatsu; Frank A Welsh; János Ludwig; Hiroki Kato; Shizuo Akira; Drew Weissman
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

4.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Authors:  Nicole Casadevall; Joelle Nataf; Beatrice Viron; Amir Kolta; Jean-Jacques Kiladjian; Philippe Martin-Dupont; Patrick Michaud; Thomas Papo; Valerie Ugo; Irene Teyssandier; Bruno Varet; Patrick Mayeux
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

5.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.

Authors:  Michael S D Kormann; Günther Hasenpusch; Manish K Aneja; Gabriela Nica; Andreas W Flemmer; Susanne Herber-Jonat; Marceline Huppmann; Lauren E Mays; Marta Illenyi; Andrea Schams; Matthias Griese; Iris Bittmann; Rupert Handgretinger; Dominik Hartl; Joseph Rosenecker; Carsten Rudolph
Journal:  Nat Biotechnol       Date:  2011-01-09       Impact factor: 54.908

6.  Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.

Authors:  Sandra S Diebold; Tsuneyasu Kaisho; Hiroaki Hemmi; Shizuo Akira; Caetano Reis e Sousa
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

7.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

Review 8.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

9.  Characterization of a messenger RNA polynucleotide vaccine vector.

Authors:  R M Conry; A F LoBuglio; M Wright; L Sumerel; M J Pike; F Johanning; R Benjamin; D Lu; D T Curiel
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

10.  Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.

Authors:  Katalin Karikó; Hiromi Muramatsu; János Ludwig; Drew Weissman
Journal:  Nucleic Acids Res       Date:  2011-09-02       Impact factor: 16.971
View more
  1 in total

Review 1.  A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs.

Authors:  Karl-Josef Kallen; Andreas Theß
Journal:  Ther Adv Vaccines       Date:  2014-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.